Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: A randomized, controlled trial

Annals of Internal Medicine

Volumn 159, Issue 8, 2013, Pages 522-531

  Saliba, Faouzi ^a   Camus, Christophe ^b   Durand, François ^c   Mathurin, Philippe ^d   Letierce, Alexia ^e   Delafosse, Bertrand ^f   Barange, Karl ^g   Perrigault, Pierre François ^h   Belnard, Magali ^e   Ichaï, Philippe ^a   Samuel, Didier ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g CHU PURPAN   (France)

^h HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CORTICOSTEROID; DIURETIC AGENT; HUMAN ALBUMIN; MANNITOL; PARACETAMOL; PENICILLIN DERIVATIVE;

ACUTE LIVER FAILURE; ADULT; ADVERSE OUTCOME; ALBUMIN DIALYSIS; ARTICLE; ARTIFICIAL LIVER; AUTOIMMUNE DISEASE; BRAIN EDEMA; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DIALYSATE; DIALYSIS MEMBRANE; DRUG INTOXICATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MORTALITY; MULTICENTER STUDY; MUSHROOM POISONING; NONCELL ARTIFICIAL LIVER SUPPORT DEVICE; PATIENT SAFETY; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ALBUMINS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTENTION TO TREAT ANALYSIS; KIDNEY FUNCTION TESTS; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84885820033     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-159-8-201310150-00005     Document Type: Article

References (21)

1. Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005; 41:1179-97. [PMID: 15841455]
2. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986;6:97-106. [PMID: 3529410]
3. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-5. [PMID: 8101303]
4. Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuau J, Rueff B, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med. 1987; 107:337-41. [PMID: 3304049]
5. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648-51. [PMID: 3732998]
6. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439-45. [PMID: 2490426]
7. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002;359:558-63. [PMID: 11867109]
8. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J. 1993;39:M621-5. [PMID: 8268613]
9. Mitzner S, Klammt S, Stange J, Schmidt R. Albumin regeneration in liver support-comparison of different methods. Ther Apher Dial. 2006;10:108-17. [PMID: 16684211]
10. Felldin M, Friman S, Backman L, Siewert-Delle A, Henriksson BA, Larsson B, et al. Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Transplant Proc. 2003;35:822-3. [PMID: 12644154]
11. Lai WK, Haydon G, Mutimer D, Murphy N. The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. Intensive Care Med. 2005;31:1544-9. [PMID: 16155752]
12. Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl. 2003; 9:290-7. [PMID: 12619027]
13. Tsai MH, Chen YC, Wu CS, Ho YP, Fang JT, Lien JM, et al. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure. Int J Clin Pract. 2005;59:1289-94. [PMID: 16236082]
14. Samuel D, Ichai P, Feray C, Saliba F, Azoulay D, Arulnaden JL, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation. 2002;73:257-64. [PMID: 11821741]
15. Millis JM, Cronin DC, Johnson R, Conjeevaram H, Conlin C, Trevino S, et al. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation. 2002;74:1735-46. [PMID: 12499890]
16. Samuel D. Bioartificial liver: present and future [Letter]. Transplantation. 2003;75:1769-70. [PMID: 12777882]
17. Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660-7. [PMID: 15082970]
18. European Liver Transplant Registry. Accessed at www.ELTR.org on 23 August 2013.
19. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with nonacetaminophen-induced acute liver failure. Liver Int. 2007;27:329-34. [PMID: 17355453]
20. Camus C, Lavoué S, Gacouin A, Compagnon P, Boudjéma K, Jacquelinet C, et al. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Ther Apher Dial. 2009;13:549-55. [PMID: 19954480]
21. Novelli G, Rossi M, Ferretti G, Pugliese F, Ruberto F, Lai Q, et al. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system. Ther Apher Dial. 2009;13:404-12. [PMID: 19788457]